echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 13 kinds of medicines in short supply implement provincial-level fixed-point reserve procurement

    13 kinds of medicines in short supply implement provincial-level fixed-point reserve procurement

    • Last Update: 2022-05-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On February 25th, the Jiangsu Provincial Public Resource Trading Center forwarded the "Provincial-level fixed-point reserve procurement and supply of 13 drugs such as chlorpyrifosin injection" jointly issued by the Jiangsu Provincial Health and Health Commission, the Food and Drug Administration, and the Medical Insurance Bureau.


    According to the "Notice", the 13 kinds of medicines purchased and supplied by the provincial-level fixed-point reserves in Jiangsu Province will be distributed or commissioned by the three provincial-level storage enterprises in Jiangsu Province.


    On April 20, 2020, in order to strengthen the national supply guarantee for drugs in short supply and establish and improve the management system for the list of drugs in short supply, in accordance with the provisions of the Drug Administration Law of the People's Republic of China, and in accordance with the General Office of the State Council on further ensuring the supply and price stability of drugs in short supply.


    In the "Administrative Measures", shortage drugs refer to drugs that are approved for marketing by China's drug regulatory authorities, are clinically necessary and irreplaceable or cannot be completely replaced, and are in short supply or unstable supply within a certain period of time or within a certain area


    For the varieties in the national and provincial drug shortage lists, enterprises are allowed to make independent quotations on the provincial centralized drug procurement platform, directly link to the Internet, and medical institutions independently purchase


    The shortage of drugs is characterized by insufficient or unstable supply, and there are many influencing factors, such as unstable supply of raw materials, small clinical dosage, lack of motivation for hospitals to use drugs, support policies for low-cost drugs, etc.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.